Results of annual general meeting

Dublin, ireland, and boston ma, july 1 , 202 2 , amryt (nasdaq: amyt), a global, commercial-stage biopharmaceutical company focussed on acquiring, developing and commercializing novel treatments for rare diseases, is pleased to announce that all resolutions presented to shareholders at yesterday's annual general meeting were duly passed.
AMYT Ratings Summary
AMYT Quant Ranking